m+Medelevator.RU
← Поиск публикаций
BMC infectious diseases · 2025

A prognostic model for early risk stratification in adult community-acquired suspected CNS infections: multicenter development and external validation.

СтатьяМногоцентровое исследованиеВалидационное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Tian Fei, Liu Zhaoyang, Chen Weibi, Cui Lili, Shan Dawei, Zhang Huimin, Chai Shuting, Liu Gang, Fan Linlin, Li Guofeng, Yang Le, Zhang Jiatang, Zhao Jiahua, Hou Fengqin, Du Jianxin, Huan Xinyu, Lv Ying, Huang Xun, Zhang Rongrong, Wu Liyong, Wu Yingfeng, Zhang Yan

Аннотация

OBJECTIVE: Community-acquired central nervous system (CNS) infections remain a major cause of morbidity and mortality, particularly in resource-limited settings. Early prognostication is critical but challenged by delays in definitive diagnosis. This study aimed to develop and externally validate a simple prognostic model to support early risk stratification and intervention. METHODS: We conducted a prospective multicenter cohort study in China (NCT04722328), enrolling 1,060 adults with suspected CNS infections. Patients from four hospitals were included in the training group (n = 742) for model development, while patients from three independent hospitals formed the external validation group (n = 318). Independent predictors were identified using least absolute shrinkage and selection operator (LASSO) and multivariable logistic regression. A nomogram was constructed to estimate individualized risk. Model performance was assessed via area under the receiver operating characteristic curve (AUC), concordance index (C-index), calibration plots, decision curve analysis (DCA), and clinical impact curves (CICs). RESULTS: Six predictors were independently associated with poor outcomes: absence of headache, altered consciousness, respiratory failure, hypoproteinemia, low hemoglobin, and hyperglycemia. The model demonstrated strong discrimination in the training group (AUC 0.811; 95% CI 0.774–0.849) and excellent calibration, with DCA indicating clear clinical benefit. External validation confirmed robust performance (AUC 0.855; 95% CI 0.800–0.910), supporting the model’s generalizability. CONCLUSION: We established a prognostic model to support early identification of severe cases and guide timely comprehensive management in adult patients with suspected community-acquired CNS infections. CLINICAL REGISTRATION: ClinicalTrials.gov (NCT04722328).

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты